Imagin Medical Inc. (IMEXF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 3.4 Million CAD | -8.38% |
| 2021 | 3.87 Million CAD | -11.52% |
| 2020 | 4.37 Million CAD | -3.68% |
| 2019 | 4.54 Million CAD | -42.84% |
| 2018 | 7.95 Million CAD | 419.71% |
| 2017 | 1.53 Million CAD | -18.29% |
| 2016 | 1.87 Million CAD | 364.31% |
| 2015 | 403.3 Thousand CAD | -28.22% |
| 2014 | 561.88 Thousand CAD | 0.56% |
| 2013 | 558.77 Thousand CAD | -12.39% |
| 2012 | 637.77 Thousand CAD | -35.44% |
| 2011 | 987.83 Thousand CAD | 64.55% |
| 2010 | 600.3 Thousand CAD | -15.4% |
| 2009 | 709.57 Thousand CAD | -33.94% |
| 2008 | 1.07 Million CAD | -51.38% |
| 2007 | 2.2 Million CAD | 56.96% |
| 2006 | 1.4 Million CAD | 30.07% |
| 2005 | 1.08 Million CAD | 705.03% |
| 2004 | 134.42 Thousand CAD | -10.02% |
| 2003 | 149.38 Thousand CAD | -11.4% |
| 2002 | 168.59 Thousand CAD | 7.27% |
| 2001 | 157.17 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q3 | 292.82 Thousand CAD | -19.2% |
| 2023 Q2 | 362.41 Thousand CAD | -45.84% |
| 2023 Q1 | 669.21 Thousand CAD | -39.08% |
| 2022 Q1 | 779.88 Thousand CAD | -41.96% |
| 2022 FY | 3.54 Million CAD | -8.38% |
| 2022 Q4 | 1.09 Million CAD | 25.84% |
| 2022 Q3 | 872.95 Thousand CAD | 9.44% |
| 2022 Q2 | 797.63 Thousand CAD | 2.28% |
| 2021 Q2 | 897.39 Thousand CAD | 36.25% |
| 2021 Q1 | 658.65 Thousand CAD | -4.25% |
| 2021 FY | 3.87 Million CAD | -11.52% |
| 2021 Q4 | 1.34 Million CAD | 37.97% |
| 2021 Q3 | 973.95 Thousand CAD | 8.53% |
| 2020 Q4 | 687.92 Thousand CAD | 18.44% |
| 2020 FY | 4.37 Million CAD | -3.68% |
| 2020 Q1 | 1.23 Million CAD | -9.44% |
| 2020 Q2 | 1.86 Million CAD | 50.76% |
| 2020 Q3 | 580.8 Thousand CAD | -68.93% |
| 2019 Q1 | 1.02 Million CAD | -52.84% |
| 2019 FY | 4.54 Million CAD | -42.84% |
| 2019 Q4 | 1.36 Million CAD | 15.55% |
| 2019 Q3 | 1.18 Million CAD | 22.28% |
| 2019 Q2 | 969.09 Thousand CAD | -5.2% |
| 2018 Q4 | 2.16 Million CAD | 22.1% |
| 2018 Q3 | 1.77 Million CAD | -34.91% |
| 2018 FY | 7.95 Million CAD | 419.71% |
| 2018 Q2 | 2.72 Million CAD | 112.49% |
| 2018 Q1 | 1.28 Million CAD | 249.42% |
| 2017 Q3 | 297.5 Thousand CAD | -21.99% |
| 2017 FY | 1.53 Million CAD | -18.29% |
| 2017 Q4 | 367.27 Thousand CAD | 23.45% |
| 2017 Q2 | 381.37 Thousand CAD | -21.2% |
| 2017 Q1 | 483.97 Thousand CAD | -24.97% |
| 2016 Q1 | 139.34 Thousand CAD | 23.01% |
| 2016 FY | 1.87 Million CAD | 364.31% |
| 2016 Q4 | 645.04 Thousand CAD | 0.25% |
| 2016 Q3 | 643.44 Thousand CAD | 23.97% |
| 2016 Q2 | 519.02 Thousand CAD | 272.46% |
| 2015 Q2 | 100.78 Thousand CAD | -4.93% |
| 2015 Q4 | 113.27 Thousand CAD | 36.11% |
| 2015 Q3 | 83.22 Thousand CAD | -17.42% |
| 2015 FY | 403.3 Thousand CAD | -28.22% |
| 2015 Q1 | 106.01 Thousand CAD | -20.95% |
| 2014 Q1 | 92.04 Thousand CAD | -32.09% |
| 2014 FY | 561.88 Thousand CAD | 0.56% |
| 2014 Q2 | 102.32 Thousand CAD | 11.16% |
| 2014 Q4 | 134.12 Thousand CAD | -42.53% |
| 2014 Q3 | 233.38 Thousand CAD | 128.08% |
| 2013 Q1 | 143.07 Thousand CAD | 0.92% |
| 2013 FY | 558.77 Thousand CAD | -12.39% |
| 2013 Q4 | 135.54 Thousand CAD | -8.77% |
| 2013 Q3 | 148.57 Thousand CAD | 12.92% |
| 2013 Q2 | 131.57 Thousand CAD | -8.04% |
| 2012 Q4 | 141.77 Thousand CAD | -22.88% |
| 2012 Q3 | 183.84 Thousand CAD | -4.38% |
| 2012 FY | 637.77 Thousand CAD | -35.44% |
| 2012 Q2 | 192.26 Thousand CAD | 60.36% |
| 2012 Q1 | 119.89 Thousand CAD | -26.1% |
| 2011 Q3 | 577.61 Thousand CAD | 346.12% |
| 2011 FY | 987.83 Thousand CAD | 64.55% |
| 2011 Q4 | 162.25 Thousand CAD | -71.91% |
| 2011 Q1 | 118.48 Thousand CAD | -21.72% |
| 2011 Q2 | 129.47 Thousand CAD | 9.28% |
| 2010 Q2 | 128.85 Thousand CAD | -35.0% |
| 2010 Q3 | 119.91 Thousand CAD | -6.94% |
| 2010 Q4 | 151.35 Thousand CAD | 26.23% |
| 2010 Q1 | 198.24 Thousand CAD | -28.59% |
| 2010 FY | 600.3 Thousand CAD | -15.4% |
| 2009 FY | 709.57 Thousand CAD | -33.94% |
| 2009 Q4 | 277.61 Thousand CAD | 93.77% |
| 2009 Q3 | 143.27 Thousand CAD | -6.82% |
| 2009 Q1 | 134.92 Thousand CAD | -50.27% |
| 2009 Q2 | 153.75 Thousand CAD | 13.96% |
| 2008 Q2 | 190.04 Thousand CAD | -47.98% |
| 2008 FY | 1.07 Million CAD | -51.38% |
| 2008 Q4 | 271.34 Thousand CAD | 9.64% |
| 2008 Q3 | 247.47 Thousand CAD | 30.22% |
| 2008 Q1 | 365.31 Thousand CAD | 306.95% |
| 2007 FY | 2.2 Million CAD | 56.96% |
| 2007 Q1 | 279.17 Thousand CAD | 6.57% |
| 2007 Q3 | 218.77 Thousand CAD | -86.51% |
| 2007 Q4 | 89.76 Thousand CAD | -58.97% |
| 2007 Q2 | 1.62 Million CAD | 480.84% |
| 2006 Q1 | 132.25 Thousand CAD | -25.51% |
| 2006 Q2 | 342.87 Thousand CAD | 159.25% |
| 2006 Q3 | 670.47 Thousand CAD | 95.54% |
| 2006 Q4 | 261.95 Thousand CAD | -60.93% |
| 2006 FY | 1.4 Million CAD | 30.07% |
| 2005 Q3 | 424.08 Thousand CAD | 400.95% |
| 2005 Q4 | 177.55 Thousand CAD | -58.13% |
| 2005 Q2 | 84.65 Thousand CAD | -78.61% |
| 2005 Q1 | 395.85 Thousand CAD | 996.48% |
| 2005 FY | 1.08 Million CAD | 705.03% |
| 2004 Q4 | 36.1 Thousand CAD | -8.28% |
| 2004 Q1 | 26.23 Thousand CAD | -37.42% |
| 2004 Q3 | 39.36 Thousand CAD | 20.27% |
| 2004 Q2 | 32.72 Thousand CAD | 24.76% |
| 2004 FY | 134.42 Thousand CAD | -10.02% |
| 2003 Q1 | 32.62 Thousand CAD | -20.78% |
| 2003 FY | 149.38 Thousand CAD | -11.4% |
| 2003 Q2 | 35.57 Thousand CAD | 9.05% |
| 2003 Q4 | 41.91 Thousand CAD | 6.21% |
| 2003 Q3 | 39.46 Thousand CAD | 10.93% |
| 2002 Q3 | 40.16 Thousand CAD | -12.55% |
| 2002 Q4 | 41.18 Thousand CAD | 2.55% |
| 2002 FY | 168.59 Thousand CAD | 7.27% |
| 2002 Q1 | 40.14 Thousand CAD | 0.0% |
| 2002 Q2 | 45.92 Thousand CAD | 14.41% |
| 2001 FY | 157.17 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| QHSLab, Inc. | 961.65 Thousand USD | -253.736% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Aurora Spine Corporation | 8.65 Million USD | 60.708% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | -100.624% |
| Avitar, Inc. | 3.56 Million USD | 4.701% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 5.25 Million USD | 35.214% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -383.885% |
| Össur hf. | 396.18 Million USD | 99.141% |
| Össur hf. | 396.18 Million USD | 99.141% |
| CVR Medical Corp. | - USD | -Infinity% |
| Stratec SE | 46.32 Million USD | 92.656% |
| Vycor Medical, Inc. | 1.27 Million USD | -166.704% |
| BrainsWay Ltd. | 28.01 Million USD | 87.859% |
| Kelyniam Global, Inc. | 2.27 Million USD | -49.51% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| Positron Corporation | 1 Million USD | -237.711% |
| Wellstar International, Inc. | 1.79 Million USD | -89.543% |
| Vivos Inc. | 2.78 Million USD | -22.052% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 42.812% |
| Heart Tronics, Inc. | 14.46 Million USD | 76.475% |
| REMSleep Holdings, Inc. | 1.01 Million USD | -235.176% |
| AVITA Medical, Inc. | 80.77 Million USD | 95.789% |
| Theraclion SA | 7.43 Million USD | 54.277% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 89.868% |
| BioElectronics Corporation | 740.67 Thousand USD | -359.271% |
| Zecotek Photonics Inc. | 3.46 Million USD | 1.726% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 84.38% |
| Nanomix Corporation | 8.36 Million USD | 59.347% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | -162.766% |
| NewCardio, Inc. | 9.56 Million USD | 64.433% |
| Electromedical Technologies, Inc. | 3.11 Million USD | -9.364% |
| Lombard Medical, Inc. | 30.29 Million USD | 88.77% |
| ALR Technologies Inc. | 6.33 Million USD | 46.311% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -2722.389% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.675% |
| VMS Rehab Systems, Inc. | 63.63 USD | -5345983.608% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 2.613% |
| Ingen Technologies, Inc. | 1.88 Million USD | -80.729% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -681.105% |
| Odyssey Group International, Inc. | -14.26 Million USD | 123.853% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 75.961% |
| IR-Med Inc. | 4.89 Million USD | 30.492% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -1547.965% |
| United American Healthcare Corporation | 59 Thousand USD | -5665.615% |
| Polarean Imaging plc | 12.24 Million USD | 72.214% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -734.807% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -435.966% |
| Medical Supply International USA, Inc. | 1.32 Million USD | -157.609% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -169.265% |
| SS Innovations International, Inc. | 21.38 Million USD | 84.091% |
| Urologix, Inc. | 10.09 Million USD | 66.293% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -1377.458% |
| Smith & Nephew plc | 3.46 Billion USD | 99.902% |
| NIOX Group Plc | 22.27 Million USD | 84.73% |
| Fuse Medical, Inc. | 10.35 Million USD | 67.133% |
| Broncus Holding Corporation | 38.15 Million USD | 91.084% |
| Brain Scientific Inc. | 9.66 Million USD | 64.796% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 66.983% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -5504.325% |